Supporters

TBA

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/innovativemedicine/emea/.
Follow us at https://www.linkedin.com/company/jnj-innovative-medicine-emea/ for our latest news.

TBA

Newron Pharmaceuticals SpA is a biopharmaceutical company dedicated to developing innovative therapies for patients with diseases of the central and peripheral nervous system. Founded in 1999 and headquartered in Bresso, near Milan, Italy, with a subsidiary in Morristown, NJ, USA, the company focuses on addressing significant unmet medical needs in difficult-to-treat conditions such as Treatment-resistant schizophrenia, Parkinson’s disease, and other areas where therapeutic innovation has been limited for decades. Building on >25 years of proprietary scientific research and clinical development, Newron’s multidisciplinary team of approximately 30 scientists, researchers, and clinicians works to advance novel drug candidates from discovery through clinical development toward commercialization. Address: via Antonio Meucci 3 20091 Bresso (MI) Italy

TBA

Visit the Wisepress stand to view our extensive range of books and journals relevant to this conference. We work with multiple publishers to ensure that our books are the best available in your specialism.
Wisepress.com is Europe’s leading conference bookseller, attending 150 conferences a year with titles also available on our online bookshop at www.wisepress.com. Want to make a bulk order? Contact us at bookshop@wisepress.com